Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
William Murphy
AddedApr 2, 2024
UpdatedMay 31, 2026
William Murphy

William Murphy

Co-Founder, Stem Pharm

Crunchbase

William Murphy's Career

Stem Pharm
Stem Pharm

Madison, WI, US

Co-Founder
Cellular Logistics
Cellular Logistics

Madison, WI, US

Board Member· Board
Dianomi Therapeutics
Dianomi Therapeutics

Madison, WI, US

Co-Founder
Tissue Regeneration Systems
Tissue Regeneration Systems

Kirkland, WA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

William Murphy's Career

Stem Pharm
Stem Pharm
Angel$683.3k62015Madison, WI, US
Co-Founder

Leadership at Stem Pharm

Steven VisuriSteven VisuriCEO
Connie LebakkenConnie LebakkenCo-Founder

Similar to Stem Pharm

StemtechStemtechMiramar Beach, FL, USNutrition, Stem Cellest. 2005StemtechMiramar Beach, FL, US · est. 2005

Stemtech, a pioneering pharmaceutical company, specializes in stem cell and nutrition solutions.

Public456
StemgenicsStemgenicsSeattle, WA, USStem Cells, Therapeuticsest. 2008StemgenicsSeattle, WA, US · est. 2008

Stemgenics develops technology to convert mature skin cells into personalized stem cells for tissue regeneration.

Angel · $3.5M3
StemBioSysStemBioSysSan Antonio, TX, USStem Cell Technologyest. 2010StemBioSysSan Antonio, TX, US · est. 2010

StemBioSys Inc. develops and manufactures advanced stem cell technologies for regenerative medicine.

Public · $14.4M39
Stemina Biomarker DiscoveryStemina Biomarker DiscoveryMadison, WI, USBiomarkersest. 2006Stemina Biomarker DiscoveryMadison, WI, US · est. 2006

Stemina Biomarker Discovery, based in Madison, US, enhances drug safety and human health through molecular biomarkers.

Seed · $16.4M35
Cellular Logistics
Cellular Logistics
Angel$1.7M52016Madison, WI, US
Board Member· Board

Leadership at Cellular Logistics

Alex VodenlichAlex VodenlichCEO
Rick SoniRick SoniBoard Member
Amish RavalAmish RavalBoard Member
Eric SchmuckEric SchmuckFounder
Scott Fisher, PhDScott Fisher, PhDBoard Member

Similar to Cellular Logistics

CelularityCelularityFlorham Park, NJ, USCell Therapiesest. 2016CelularityFlorham Park, NJ, US · est. 2016

Celularity, a US-based biotech firm, pioneers in delivering large-scale, quality allogeneic placenta-derived cellular therapies.

Public · $400M225
Cellular ApproachesCellular ApproachesLos Angeles, CA, USCell Therapiesest. 2016Cellular ApproachesLos Angeles, CA, US · est. 2016

Cellular Approaches: Innovating in innate immunity biotech for unmet medical needs.

Seed · $2.6M5
ElutiaElutiaSilver Spring, MD, USMedical Devicesest. 2015ElutiaSilver Spring, MD, US · est. 2015

Elutia, a biotech firm, innovates in regenerative medicine, focusing on advanced cardiac and vascular surgery solutions.

Public · $69.8M164
BioCardiaBioCardiaSan Carlos, CA, USMedical Devices, Therapeuticsest. 1999BioCardiaSan Carlos, CA, US · est. 1999

BioCardia, a San Carlos-based medical firm, develops innovative regenerative therapies for critical cardiovascular diseases.

Public · $41.3M28
Dianomi Therapeutics
Dianomi Therapeutics
Seed$3.2M62017Madison, WI, US
Co-Founder

Leadership at Dianomi Therapeutics

Martin OstrowskiMartin OstrowskiCo-Founder
Barry KurokawaBarry KurokawaCo-Founder
Carter CliffCarter CliffCo-Founder

Similar to Dianomi Therapeutics

NanoPharmaceuticalsNanoPharmaceuticalsRensselaer, NY, USTherapeuticsest. 2013NanoPharmaceuticalsRensselaer, NY, US · est. 2013

Clinical-stage company innovating targeted therapeutics for cancer and inflammatory diseases.

Pre-Seed · $6M7
ZenomicsZenomicsDurham, NC, USDrug Deliveryest. 2015ZenomicsDurham, NC, US · est. 2015

Zenomics: Innovating diabetes treatment through advanced drug delivery systems.

Seed · $2.8M8
DermBiontDermBiontBoston, MA, USTherapeuticsest. 2017DermBiontBoston, MA, US · est. 2017

DermBiont: A leading precision dermatology firm, developing targeted therapeutics for skin health.

Series B · $108.5M47
Dose TherapeuticsDose TherapeuticsDallas, TX, USMedicinesest. 2021Dose TherapeuticsDallas, TX, US · est. 2021

Dose Therapeutics: A biotech firm innovating advanced medicines for unmet medical needs.

Series A · $10M5
Tissue Regeneration Systems
Tissue Regeneration Systems
Series A$18.3M302005Kirkland, WA, US
Board Member· Board

William Murphy's Similar Executives & Operators

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance Retail

People Similar to William Murphy

Bruce MarkhamBruce MarkhamCo-Founder · Phrixus PharmaceuticalsDavid ThompsonDavid ThompsonCo-Founder · Azure BiotechMario FeldmanMario FeldmanCo-Founder · OmnioseCameron PittCameron PittCo-Founder · Quanta TherapeuticsRonald MurphyRonald MurphyCEO · Theromics